Yesterday, the President & CSO of Karyopharm Therapeutics (KPTI – Research Report), Sharon Shacham, sold shares of KPTI for $281.6K.
Tag: Sharon Shacham
Yesterday, the President & CSO of Karyopharm Therapeutics (KPTI – Research Report), Sharon Shacham, sold shares of KPTI for $281.6K.